Merck Overview

  • Year Founded
  • 1891

Year Founded

  • Status
  • Public

  • Employees
  • 62,908


  • Stock Symbol
  • MRK

Stock Symbol

  • Investments
  • 94

  • Share Price
  • $164.76
  • (As of Friday Closing)

Merck General Information


Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Specialty Chemicals
Stock Exchange
Corporate Office
  • Frankfurter Strasse 250
  • 64293 Darmstadt
  • Germany
+49 06151 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$164.76 $163.10 $142.58 - $185.08 $71.6B 435M 287K $7.02

Merck Financials Summary

In Thousands,
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 78,270,177 78,270,177 92,853,805 122,614,673
Revenue 22,716,009 22,716,009 23,374,794 23,275,913
EBITDA 5,859,438 5,859,438 6,578,629 6,995,661
Net Income 3,055,781 3,055,781 3,496,967 3,611,922
Total Assets 53,606,367 53,606,367 52,048,816 51,359,797
Total Debt 10,903,664 10,903,664 11,150,790 12,189,488
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merck Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.

Request a free trial

Merck Comparisons

HQ Location
Total Raised
Post Valuation
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segm
Darmstadt, Germany
62,908 As of 2023
000000000 00.00


nt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
Basel, Switzerland
00000 As of 0000
000000000 0000


ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
Mumbai, India
00000 As of 0000
00000 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merck Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Cipla Corporation Mumbai, India 00000 000000&0
AbbVie Corporation North Chicago, IL 00000 000.00 000000000 000.00
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
Bayer Corporation Leverkusen, Germany 00000 000.00 000000000 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Merck Patents

Merck Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202402032-D0 Device, method for producing a liquid crystal cell, and method for operating a device Pending 17-Feb-2023
EP-4349842-A1 Hydroxyaminophosphinic acid derivatives Pending 04-Oct-2022 00000000
US-20240079249-A1 Atomic layer etching method using ligand exchange reaction Pending 05-Sep-2022 000000000000
JP-2024032685-A Heterocyclic compounds for liquid crystals Pending 29-Aug-2022 00000000000
EP-4332198-A1 Heterocyclic compounds for liquid crystals Pending 29-Aug-2022 C09K19/3497 0
To view Merck’s complete patent history, request access »

Merck Executive Team (60)

Name Title Board Seat Contact Info
Belén Garijo Chair of the Executive Board & Chief Executive Officer
Kai Beckmann Ph.D Member of the Executive Board & Chief Executive Officer, Electronics
Renee Connolly Chief Diversity, Equity & Inclusion Officer & Head of Innovation HR Engagement & Inclusion
Julia Zakrzewska Associate Consultant
Vene Freysen Director & Head of Branding, Product Marketing & Communications
You’re viewing 5 of 60 executive team members. Get the full list »

Merck Board Members (25)

Name Representing Role Since
000000000 0000 Merck Member of the Supervisory Board 000 0000
0000 00000 Merck Supervisory Board Member 000 0000
000é0 000000 Merck Chair of the Executive Board & Chief Executive Officer 000 0000
000000 00000000 Self Board Member 000 0000
000000000 00000 00 Merck Supervisory Board Member 000 0000
You’re viewing 5 of 25 board members. Get the full list »

Merck Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Investments & Acquisitions (94)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Loma Therapeutics 01-Dec-2023 00000 000.00 Biotechnology
DenovAI 28-Feb-2023 0000 00000 000 Biotechnology
Genopore 27-Feb-2023 0000 00000 00.000 Other Healthcare Technology Systems
Mecaro (Chemical Business) 02-Jan-2023 0000000000 00000 Multi-line Chemicals 000 00000
Erbi Biosystems 01-Dec-2022 Merger/Acquisition Discovery Tools (Healthcare)
You’re viewing 5 of 94 investments and acquisitions. Get the full list »

Merck Subsidiaries (20)

Company Name Industry Location Founded
Exelead Pharmaceuticals Indianapolis, IN 2017
ConnectMed Outcome Management (Healthcare) Kenya 0000
Merck Innovation Center Accelerator/Incubator Darmstadt, Germany 0000
Chord Therapeutics Drug Discovery Geneva, Switzerland 0000
M Ventures Corporate Venture Capital Amsterdam, Netherlands 0000
You’re viewing 5 of 20 subsidiaries. Get the full list »

Merck ESG

Risk Overview

Risk Rating

Updated December, 13, 2023

17.97 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,173






00 of 909






0. of 444




To view Merck’s complete esg history, request access »

Merck Exits (22)

Company Name Exit Date Exit Type Exit Size Status Buyers
MoonLake Immunotherapeutics 01-Jan-2021 00000 00000 00 Completed
  • 2 buyers
Seagen 14-Sep-2020 0000 000 Completed
  • 00000
breathe ilo 31-Jan-2020 000000000000000000 000.00 Completed
  • 00000
Akili Labs 29-Aug-2019 000000000000000000 000.00 Completed
  • 2 buyers
Nanolek 14-Aug-2019 Secondary Transaction - Private 000.00 Completed
  • 2 buyers
You’re viewing 5 of 22 exits. Get the full list »

Merck FAQs

  • When was Merck founded?

    Merck was founded in 1891.

  • Who is the CEO of Merck?

    Belén Garijo and Kai Beckmann Ph.D are the CEOs of Merck.

  • Where is Merck headquartered?

    Merck is headquartered in Darmstadt, Germany.

  • What is the size of Merck?

    Merck has 62,908 total employees.

  • What industry is Merck in?

    Merck’s primary industry is Pharmaceuticals.

  • Is Merck a private or public company?

    Merck is a Public company.

  • What is Merck’s stock symbol?

    The ticker symbol for Merck is MRK.

  • What is the current stock price of Merck?

    As of 12-Apr-2024 the stock price of Merck is $164.76.

  • What is the current market cap of Merck?

    The current market capitalization of Merck is $71.6B.

  • What is Merck’s current revenue?

    The trailing twelve month revenue for Merck is $22.7B.

  • Who are Merck’s competitors?

    Novartis, Cipla, AbbVie, Merck & Co., and Bayer are some of the 25 competitors of Merck.

  • What is Merck’s annual earnings per share (EPS)?

    Merck’s EPS for 12 months was $7.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »